Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.

Recs

0
Player Avatar Biotech2010 (87.49) Submitted: 1/26/2010 8:56:24 PM : Outperform Start Price: $2.60 IDIX Score: +251.30

2.18

Featured Broker Partners


Advertisement